Tag: COIN

Options Runner Recap, Fresh Ideas & More

Winning Options Review:

We’ll make this a brief recap, because we want our readers to have plenty of time to check out the link we’ve provided further down the page!

As usual, we issued some fresh options ideas in yesterday morning’s premarket report. Our interest in the CHGG 08/20 $80-85 Calls and the SYY Weekly $75-76.50 Calls paid immediate dividends as both companies produced some nice intraday activity in the wake of their earnings reports.

Here are the total possible intraday gains that could have been secured following our alerts:

CHGG 08/20 $80-85 Calls
$80: 2.90-6.20 (+114%)
$85: .90-2.75 (+205%)
_____

SYY Weekly $75-76.50 Calls
$75: 1.08-3.70 (+245%)
$75.50: .99-3.15 (+218%)
$76: .55-2.75 (+418%)
$76.50: .51-2.32 (+355%)
_____

Fresh Options Ideas:
COIN Weekly $275-280 Calls
U 08/20 $110-115 Calls
WEN 08/20 $22-23 Calls 

SPECIAL REMINDER: 

As we were mentioning yesterday morning, we’re excited to be able to make a special presentation of a high-potential stock that has piqued our interest. We would suggest that our readers click here to check out this special report in addition to today’s newsletters.

Extended Watchlist:
CWBR, GTIM, MOGO, FUBO, PDGO, FLRE, IFAN, XTRM

Explosive Gains in the YETI Chain & More

More SPY Updates:

In yesterday morning’s premarket report, we mentioned that we felt the markets were due for a reversal off of the bearish trend they had established up to that point. After tracking some very nice gains in SPY Puts over that span, we flip-flopped and targeted some SPY Calls fresh for yesterday’s report.

Those were the SPY 05/14 $406-407.50 Calls and they produced considerable intraday movement that could have been seized upon by anyone who caught our alert. Here are the double-bag moves and total possible gains that were on the table there:

 SPY 05/14 $406-407.50 Calls.
$406: 3.32-6.70 (+102%)
$407: 2.76-5.82 (+111%)
$407.50: 2.46-5.40 (+120%)

We also want to roll up to the SPY 05/14 $411-412.50 Calls* for today’s session.

YETI Holdings Inc. YETI

We also formulated some ideas for the YETI chain that recorded some simply earth-shattering gains on the day yesterday. The was the star idea of our daily report, yielding some truly fantastic gain opportunities for ourselves and our readers.

Uncovering gainers of such magnitude is a common occurrence on our newsletters and website (BlueHorseshoeStocks.com), and still, every time it happens it produces a similar feeling of exhilaration! Here were the absolutely massive intraday runs logged by those calls.

YETI Weekly $83-85 Calls 
$83: .48-3.10 (+546%)
$84: .05-2.50 (+4900%)
$85: .10-1.87 (+1770%)

Fresh Options Ideas:
COIN Weekly $270-277.50 Calls*
DASH Weekly $122-125 Calls*
FTCH 05/21 $35-40 Calls
PBR Weekly $9-9.50 Calls* 

*Please remember that trading options on their day of expiration should only be attempted by advanced level traders with access to disposable funds!  

Extended Watchlist:
GGII, TAWNF, ICBU, PMBY, BYRG, MTVX, SDVI, SVSN, GEGI, EEGI

BMSN, CERP, COIN & Extended Watchlist

Bio-Matrix Scientific Group, Inc. BMSN

BMSN is a really good example of why we suggest that our readers keep a working watchlist of all of the stocks we mention, as there are instances when one of our more dated interests crops up with a new development that sends the stock on a ride. Such was the case with BMSN yesterday, as the company released a PR iterating the initiation of clinical trials for the company’s anemia treatment, HemaXellerate. As a result, yesterday’s trading carried the stock as high as .0062.

A week ago today, we mentioned that we’d like to see support hold at .0035 and .0021 to remain bullish on BMSN, which it did, in fact, manage. From the low of .0032 since last Wednesday’s mention, we are up 94% – From the low following our first ever alert (.0003 on Dec. 26th), yesterday’s high represented an unbelievably impressive gain of 1967%

Regen BioPharma Files Investigational New Drug (IND) Application With FDA on HemaXellerate I(TM) Stem Cell Drug for Aplastic Anemia

Clinical Trial to Evaluate “First in Class” Approach to Bone Marrow Failure Diseases

SAN DIEGO, CA, Feb 05, 2013 (MARKETWIRE via COMTEX) — Regen BioPharma a wholly-owned subsidiary of Bio-Matrix Scientific Group Inc. (PINKSHEETS: BMSN), announced today filing of an Investigational New Drug (IND) application with the FDA to initiate clinical trials assessing the company’s HemaXellerate I(TM) stem cell drug in patients with drug-refractory aplastic anemia.
___

Cereplast, Inc. CERP

We first mentioned CERP as a feature on January 24th, at which time we saw a low of .023. On the 25th, it spiked 59% to .0365. This past Friday the stock saw another low of .0182, before running yesterday to a new high at .043, for an added gain of 136%, and bringing our total cumulative gains to 195% in just under two weeks’ time.

With the amount of momentum and volume we’ve seen trade through CERP recently, we definitely want to keep this one high on our watchlists.

Cereplast Provides Shareholder Update on Italian Application Decree & Announces $300,000 in New Revenue

EL SEGUNDO, Calif., Feb 05, 2013 (GLOBE NEWSWIRE via COMTEX) — Cereplast, Inc. (OTCQB:CERP) (the “Company”), a leading manufacturer of proprietary biobased, compostable and sustainable bioplastics, generated approximately $300,000 in new revenue during the last two weeks of January 2013. These orders received are in addition to the $500,000 of new revenue that was announced on January 23, 2013.

___

Converted Organics, Inc. COIN

 COIN appeared on our extended watchlist yesterday, and thus posted a sizable gain, running from .0019-0029, only to close the day at .0025. That gave us a quick chance at up to 53% in intraday gains.
___

As most of you are undoubtedly aware, we first began really zeroing in on cannabis stocks back in October. From our continued reports on the subject this week, we have seen even more gains to add to the already monumental profits that these plays have afforded us. Our running tally of tracked pot stocks totaled 10 at the start of this week. We are all but certain that even more will crop up (no pun intended), as the fervor over this newly expanding market sector continues to intensify.
___

Extended Watchlist:
SFOR, SCXN, CCRY, JOEZ, CNAM, CLSN